Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.

Company Data

Name Cyclo Therapeutics, Inc. - Warrant

Company Cyclo Therapeutics, Inc.

Symbol CYTHW

Website http://www.cyclotherapeutics.com

Primary Exchange

NASDAQ

ISIN US23254X1101

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO N. Scott Fine

Country United States of America

Currency USD

Employees 0,0 T

Address 6714 NW 16th Street, Gainesville

IPO Date 2020-12-18

Ticker Symbols

Name	Symbol
NASDAQ	CYTHW

More Shares

Investors who hold Cyclo Therapeutics, Inc. - Warrant also have the following shares in their portfolio:

ASIAN DEV.BK 23/26 MTN Bond

NEWDAY FUNDING 2018-1 PLC CLASS F ASST BKD FLTG RTE NTS 15/08/26 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog